SAILIFE.NS Overview

Company Profile

Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It offers medicinal chemistry, pharmacokinetics, clinical and commercial manufacturing, and process development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is headquartered in Hyderabad, India.

Related stocks

LALPATHLAB.NS

LALPATHLAB.NS • India

DR. LAL PATH LABS LTD.

1,933.6 INR

3.34B USD 1Y +23.3%

VIJAYA.NS

VIJAYA.NS • India

VIJAYA DIAGNOSTIC CEN LTD

1,436.6 INR

1.53B USD 1Y +44.5%

SYNGENE.NS

SYNGENE.NS • India

SYNGENE INTERNATIONAL LTD

347.4 INR

1.44B USD 1Y -45.1%

METROPOLIS.NS

METROPOLIS.NS • India

METROPOLIS HEALTHCARE LTD

529.25 INR

1.13B USD 1Y +4.2%

6127.HK

6127.HK • China

31.32 HKD

2.99B USD 1Y +45%

300676.SZ

300676.SZ • China

45.47 CNY

2.85B USD 1Y -9.3%

THYROCARE.BO

THYROCARE.BO • India

Thyrocare Technologies Limited

499 INR

820.66M USD 1Y +22%

3347.HK

3347.HK • China

44.56 HKD

4.89B USD 1Y +3.2%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

5 Metrics

Country

Region

Sector

Industry

Diagnostics & Research

Website

https://www.sailife.com

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

3Y Volatility

-

Max Drawdown (3Y)

-

Sharpe Ratio (3Y)

-

Size Class

Mega Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 High valuation risk: Avg P/E of 87.9 (Elevated multiple compression risk)

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections